Every 11 minutes, an American dies by suicide. Millions more struggle to manage their mental health, cycling through medications, therapy and hospital visits without finding relief.
In April, the FDA took a decisive step toward addressing this prolonged health emergency. In response to President Trump’s recent executive order, the agency announced plans to expedite review of certain psychedelic medicines for serious mental health conditions.
It’s about time.
Subscribe to The Dakota Scout to read the rest of the story.
Become a paying subscriber of The Dakota Scout to get access to this post and other subscriber-only content.
SubscribeA subscription gets you:
- Daily news in your inbox
- Viewpoints, concert reviews, obituaries
- Weekly digital copy of print version
